Table 1 Characteristics of Baseline and Retested Samples
Baseline sample (n = 167) | Retested sample (n = 31) | ||
|---|---|---|---|
M±SD/n (%) | M±SD/n (%) | ||
Age | 58.2±9.6 | 57.8±9.5 | |
Gender | male | 110 (65.9%) | 12 (38.7%) |
female | 57 (34.1%) | 35 (35.4%) | |
Residence | city | 123 (73.7%) | 30 (96.8%) |
rural | 44 (26.3%) | 1 (3.2%) | |
Cancer | colorectal | 28 (16.8%) | 2 (6.5%) |
rectal | 44 (26.3%) | 2 (6.5%) | |
gastric | 37 (22.2%) | 8 (25.8%) | |
thyroid | 10 (6.0%) | 6 (19.4%) | |
other | 48 (28.7%) | 13 (41.9%) | |
Cancer periods | I | 16 (9.6%) | 2 (6.5%) |
II | 50 (29.9%) | 6 (19.4%) | |
III | 65 (38.9%) | 10 (32.3%) | |
IV | 36 (21.6%) | 13 (41.9%) | |
Past operation | yes | 67 (40.1%) | 13 (41.9%) |
no | 100 (59.9%) | 18 (58.1%) | |
Past chemotherapy | yes | 60 (35.9%) | 19 (61.3%) |
no | 107 (64.1%) | 12 (38.7%) | |
Past targeted therapy | yes | 13 (7.8%) | 5 (16.1%) |
no | 154 (92.2%) | 26 (83.9%) | |
Past radiotherapy | yes | 24 (14.4%) | 6 (19.4%) |
no | 143 (85.6%) | 25 (80.6%) |